The amino acid sequence of human placental insulin receptor precursor protein has been predicted by Ullrich et al. (5) and Ebina et al. (1) independently. Such structural informations have opened a way to explore complex biologic systems, in which the receptor protein is involved, by chemical and immunochemical manipulations with use of synthetic peptides.
As a part of our immunochemical study on the molecular basis of insulin receptor, we have examined in this study human placental and hepatic tissues radioimmunologically and immunohistochemically with use of region-specific antisera which were elicited against synthetic peptides ( Fig. 1) corresponding to purposely selected regions of human insulin receptor protein (HIRP) (1).
MATERIALS AND METHODS

Synthetic peptides
The synthetic peptides used as immunogens ( Fig. 1 Biosystems peptide synthesizer type 430B in the same manner as previously described (4) . Crude peptide preparations were purified extensively by reverse-phase high performance liquid chromatography (HPLC) on a preparative TSK-GEL ODS-120T column (2.1 X 30 cm) using 0.01 N HCl/CH3CN as eluent. High purity of each of the products was proved by amino acid analysis of acid hydrolysate and aminopeptidase-M digest of each product and analytical HPLC on a TSK-GEL ODS-120T column (0.46 X 25 cm) with 0.01 N HCl/CH3CN and 0.1 % TFA/ CH3CN as eluents. Details of the syntheses of the peptides and their physicochemical characterization will be described elsewhere. Antisera Antisera were raised against the five synthetic HIRP peptide fragments in rabbits. Three animals were used for immunization with each peptide. Synthetic peptide (0.5-1.0 mg/rabbit) was stirred in 50% polyvinylpyrrolidone (PVP) in saline (0.5 ml) at room temperature for 2 hr, which was then emulsified with complete Freund's adj uvant (0.5 ml). The emulsion was injected intracutaneously into the rabbit. Injection was repeated every two weeks using half off the amount of the immunogen used for the initial injection. Ten days after the 3rd-6th immunization when sufficiently high titer was detected, the blood was collected, from which serum was obtained in the usual manner. The antisera used in the present study include anti-HIRP(9-25) serum HIR1-1, anti-HIRP(30-61) serum HIR2-2, anti-HIRP(48-77) serum HIR3-2, anti-HIRP(736-760) serum HIR31-1 and anti-HIRP(1139-1171) serum HIR25-1.
Radioimmunoassay
Using the anti-HIRP (30-61) serum HIR 2-2 and anti-HIRP(1139-1171) serum HIR25-1, region-specific radioimmunoassays were developed, respectively. The tracers used for the assays were prepared by radioiodinating the synthetic peptides HIRP (30-61) and (1139-1171), respectively, according to chloramine T method followed by purification by gel filtration on Sephadex G 10 column. The assays were performed by double antibody method as described for PHI radioimmunoassay (7). The minimum detectable doses of the two assay systems were both 5 fmol.
Gel filtration
Human placental membrane preparation was examined by gel filtration and radioimmunoassays. Solubilized human placental membrane was prepared according to the method described by Fujita-Yamaguchi et al . (2) . The solubilized preparation was fractionated by gel filtration on a Sepharose 6B column (1.2 X 100 cm) with 50 mM Tris-HC1 buffer /150 mM NaG 1/0.1 % Triton X-100/0 .1 mM phenylmethylsulfonyl fluoride (pH 7.4) as eluent. Each fraction (2 ml) was assayed by the two region-specific radioimmunoassays for HIRP described above . Insulinbinding activity was also assayed with each fraction according to the method of Fujita-Yamaguchi et al. (2) . Immunohistochemistry
Human placenta in the 6th month of gestation and needle-biopsied human liver tissue (diagnosed as normal) from a 32-year-old male patient were used for immunostaining with anti-HIRP fragment sera HIRI-l, HIR2-2, HIR3-2, HIR31-l and HIR25-l.
Formalin-fixed cryostat sections of the placental tissue and formalinfixed paraffin embedded sections of the hepatic tissue were immunostained by the five anti-HIRP fragment sera according to peroxidase-antiperoxidase method and according to peroxidase-labeled antibody method, respectively. The anti-HIRP fragment sera were used at a dilution of 1 : 3000 for the placental tissue and 1 : 200 for the hepatic tissue.
RESULTS AND DISCUSSION
Synthetic peptides HIRP (9-25), (30-61) and (48-77) correspond to extremely N-terminal regions of the a-subunit of HIRP and HIRP(736-760) to the most N-terminal region of the 9-subunit. These regions are supposed to be in the extracellular structure of the receptor. On the other hand, HIRP (1139-1171) corresponds to a middle portion of the 9-subunit which is one of the predicted intracellular functional regions, i.e. a kinase activity domain. These synthetic peptides consist of 17-33 amino acid residues and were sufficiently immunogenic by themselves; antisera of titers high enough to be used for either radioimmunoassay or immunohistochemistry could be elicited against the peptides in rabbits. We purposely used these synthetic peptides as immunogens without conjugating with macromolecules to preserve their intact chemical structures. This procedure for antiserum production has been well established in our laboratory (6) .
On gel filtration of solubilized human placental membrane preparation, radioimmunoassays with use of anti-HIRP(30-61) serum HIR2-2 and anti-HIRP (1139-1171) serum HIR25-1 both revealed a main peak of immunoreactivity, which eluted in a position corresponding to a molecular size of approximately 270 K daltons. This immunoreactive peak was overlapped with one of the two peak components of insulin-binding activity. The other peak component of insulinbinding activity was in a molecular size of approximately 850 k daltons and showed very low immunoreactivity when measured by the HIR2-2 and HIR25-1 radioimmunoassays. It may be presumed that the smaller-size component represents a monomeric form of combined a-and 9-subunits of HIRP and the larger-size component a tetramerized form of the mononer (3). The (31-60) and (1139-1171) sequence regions in the tetrameric form of a9-monomer may hardly be recognized by either antiserum HIR2-2 or antiserum HIR25-1 conceivably because of steric hindrance in the aggregated form or marked alteration of the steric conformations of the peptide regions in the large molecule from those of synthetic peptides used as antigens.
The five anti-synthetic peptide sera successfully stained both human placental and hepatic tissues. In the placenta, Hofbauer cells in the chorionic villi were stained with any of the five antisera used; particularly strong immunostaining was observed around the cell membranes (Figs. 2a, b) . In the liver, on the other hand, strongly and slightly stained hepatocytes were intermingled; especially sinusoidal sites of the hepatocytes were strongly stained (Figs. 3a, b) . It showed small granular FIGS. 2a, b. Immunostaining of human placenta (a) with anti-HIRP (48-77) serum HIR3-2 (x 3000) and (b) with anti-HIRP (1139-1171) serum HIR25-1 (x 3000). Fig. 2a. x700, Fig. 2b however, do not provide us sufficient definite clues for our understanding of the functional features of such proteins in physiological as well as pathophysiological states.
Our immunochemical manipulations with use of anti-synthetic peptide sera will be a method of choice for studies on the functions and molecular mechanisms of not only insulin receptor but also other functional proteins which amino acid sequences have been predicted.
